Sarcoma Nomogram: Validation and a Model to Evaluate Impact of Therapy

Journal of the American College of Surgeons

Volumn 205, Issue 4 SUPPL., 2007, Pages

  Eilber, Frederick C ^a   Kattan, Michael W ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; IFOSFAMIDE;

ADULT; CANCER GRADING; CANCER MODEL; CANCER MORTALITY; CANCER PATIENT; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; DRUG MEGADOSE; EDITORIAL; FIBROSARCOMA; HIGH RISK PATIENT; HUMAN; LIPOSARCOMA; MALIGNANT FIBROUS HISTIOCYTOMA; NOMOGRAM; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; SOFT TISSUE SARCOMA; VALIDATION PROCESS;

FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; MODELS, BIOLOGICAL; NOMOGRAMS; PROSPECTIVE STUDIES; SARCOMA; SOFT TISSUE NEOPLASMS;

EID: 34748822246     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2007.06.335     Document Type: Editorial

References (25)

1. Brennan M., Alektiar K.M., and Maki R.G. Soft tissue sarcoma. In: DeVita V.T., Hellmann S., and Rosenberg S.A. (Eds). Cancer. Principles and practice of Oncology (2001), Lippincott Williams & Wilkins, Philadelphia 1841-1891
2. Eilber F.C., and Eilber F.R. Soft tissue sarcoma. In: Cameron (Ed). Current Surgical Therapy. Seventh Edition (2001), Mosby, St Louis 1213-1218
3. Coindre J.M., Terrier P., Bui N.B., et al. Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study on 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol 14 (1996) 869-877
4. Pisters P.W.T., Leung D.H.Y., Woodruff J., et al. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 14 (1996) 1679-1689
5. Eilber F.C., Rosen G., Nelson S., et al. High grade extremity soft tissue sarcomas: Factors predictive of local recurrence and its effect on morbidity and mortality. Ann Surg 237 2 (2003) 218-226
6. Kattan M.W., Leung D.H., and Brennan M.F. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol 20 (2002) 791-796
7. AJCC Cancer Staging Manual. Sixth Edition (2002), Springer-Verlag, New York 193-197
8. Sarcoma Meta-analysis Collaboration Adjuvant chemotherapy for localized resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Lancet 350 (1999) 1647-1654
9. Frustaci S., Gherlinzoni F., De Paoli A., et al. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. J Clin Oncol 19 (2001) 1238-1247
10. Eilber F.C., Rosen G., Eckardt J., et al. Treatment induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high grade extremity soft tissue sarcomas. J Clin Oncol 19 (2001) 3203-3209
11. Eilber F.C., Eilber F.R., Eckardt J., et al. Ifosfamide based chemotherapy is associated with improved survival in patients with primary extremity synovial sarcoma. Proc ASCO (2004) (abstr #9017)
12. Eilber F.C., Eilber F.R., Eckardt J., et al. The impact of chemotherapy on the survival of patients with high-grade primary extremity liposarcoma. Ann Surg 101 (2004) 686-695
13. Graefen M., Karakiewicz P.I., Cagiannos I., et al. Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer. J Clin Oncol 20 (2002) 951-956
14. Justice A.C., Covinsky K.E., and Berlin J.A. Assessing the generalizability of prognostic information. Ann Intern Med 130 (1999) 515-524
15. Eilber F.C., Brennan M.F., Eilber F.R., et al. Validation of the postoperative nomogram for 12-year sarcoma-specific death. Cancer 15 10 (2004) 2270-2275 101
16. Rockhill B., Spiegelman D., Byrne C., et al. Validation of the Gail et al. Model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 93 5 (2001) 358-366
17. Mariani L., Miceli R., Kattan M.W., et al. Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system. Cancer 15 2 (2005) 402-408 103
18. Cormier J.N., Huang X., Xing Y., et al. Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: chemotherapy associated outcomes. J Clin Oncol 22 22 (2004) 4567-4574
19. Antman K.H., Ryan L., Elias A., et al. Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma. J Clin Oncol 7 1 (1989) 126-131 Jan
20. Brodowicz T., Schwameis E., Widder J., et al. Intensified adjuvant IFADIC chemotherapy for adult soft tissue sarcoma: a prospective randomized feasibility trial. Sarcoma 4 (2000) 151-160
21. Gortzak E., Azzarelli A., Buesa J., et al. A randomized phase II study on neo-adjuvant chemotherapy for "high-risk" adult soft-tissue sarcoma. Eur J Cancer 37 (2001) 1096-1103
22. DeLaney T.F., Spiro I.J., Suit H.D., et al. Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas. Int J Radiat Oncol Biol Phys 56 4 (2003) 1117-1127
23. Grobmyer S.R., Maki R.G., Demetri G.D., et al. Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma. Ann Oncol 15 11 (2004) 1667-1672
24. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Cancer Res Clin Oncol 53 (1958) 457-516
25. Greenwood M. Reports on public health and medical subjects. The errors of sampling of the survivorship tables (1926), H. M. Stationary Office, London